Ryan Donnelly is named as a lobbyist on federal disclosure filings for 1 client through Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, INC. The most recent filing naming them posted in October 2026. Issues reported include Animals and Budget/Appropriations.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | Q3 2026 | Animals, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Ryan Donnelly. See the Capitol Clarity rankings and method.